TriSalus Life Sciences(TLSI) - 2025 Q4 - Annual Results

Financial Results - TriSalus Life Sciences, Inc. announced preliminary unaudited financial results for Q4 2025 and provided revenue guidance for 2026[6]. - The press release detailing the financial results was issued on January 12, 2026[6]. - The financial statements and exhibits related to the report are included in Exhibit 99.1[8]. Company Information - The company is listed on the Nasdaq Global Market under the trading symbol TLSI[4]. - The company has not indicated whether it is an emerging growth company[5]. - The report was signed by David Patience, Chief Financial Officer, on January 12, 2026[12].